Schering-Plough - Top 13 Ad Budgets

Company:  Schering-Plough  schering.jpg
2007 Ad Spending: $1.092 billion
2006 Ad Spending: $883.6 billion


  • Magazines: $54.4 million
  • Newspaper: $6 million
  • Outdoor: $0
  • TV: $426.7 million
  • Radio: $6.1 million
  • Internet: $9.1 million

Where Schering-Plough is spending money: Schering-Plough spent $122 million promoting the allergy drug Nasonex. Another $53 million went to a 325 percent increase on advertising for the asthma drug, Asmanex. Most of the company's spending--$148.6 million--went to promoting the non-prescription allergy drug, Claritin.

Schering significantly increased its advertisements in three areas. It's spending on internet ads rose 104 percent and national newspaper placements were up 262 percent. Like GSK, Schering-Plough saw an opportunity in the Spanish-language market and boosted its budget in Spanish-language magazines ads 512 percent. All told, sales increased 19.8 percent in 2007, from $10.5 billion to $12.6 billion.

Where Schering-Plough isn't spending money: Advertising for the contraceptive NuvaRing dropped 58 percent. National and local radio budgets were down 62 percent and 71 percent, respectively. The company's newspaper advertising budget was down almost 58 percent.

Schering-Plough - Top 13 Ad Budgets

Suggested Articles

Horizon Therapeutics has notched an FDA approval for its rare eye disease med Tepezza (teprotumumab), a possible blockbuster drug in the making.

Eli Lilly has a pipeline stuffed with a host of assets and has decided it needs a new injectable drug and device plant to manufacture some of them.

After Clovis’ Rubraca snagged an FDA boost in prostate cancer last week, AZ and Merck’s rival Lynparza has matched it with a boost of its own.